BioFabUSA Manufacturing Innovation Institute (regenerative tissue manufacturing)
Abstract
BioFabUSA advances state-of-the-art human tissue manufacturing innovations in cell and biomaterial processing, bioprinting, automation, and non-destructive testing technologies. BioFabUSA is establishing a collaboration to mature tissue-related technology across manufacturing readiness levels (MRL) 4-7, enabling post-delivery assurance of tissue identity, viability, function, and efficacy. This MII is assembling a diverse and currently fragmented collection of industry practices and institutional knowledge across many disciplines (e.g., cell biology, bioengineering, materials science, analytical chemistry, robotics, and quality assurance).
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2022
- Source ID
- 6063281158bd6a7eba2a779ad8621c38